MedPath

A Study to Evaluate Safety and Feasibility of Robotic Liver Resection

Not Applicable
Recruiting
Conditions
Surgery
Liver Diseases
Registration Number
NCT06353672
Lead Sponsor
Zhejiang University
Brief Summary

The robotic surgery system, the most advanced technology in minimally invasive surgery, overcame some shortcomings of laparoscopic surgery and improved the flexibility and precision of liver resection. Several studies have demonstrated that the robotic system was safe and feasible in liver surgery and might be advantageous in complex hepatic vein and hilar dissection, operative bleeding control, and biliary reconstruction. Previous comparative studies found limited evidence for significantly improved outcomes in robotic liver resection (RLR) over laparoscopic liver resection (LLR) or open liver resection (OLR), considering the various degrees of difficulty in liver surgeries.

This study aimed to evaluate safety and feasibility of robotic liver resection, by comparing it with LLR or OLR, and gain veritable and relevant data on the benefits of RLR.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • The patients were diagnosed with a liver tumor.
  • The patients underwent robotic liver resection.
Exclusion Criteria
  • The patients underwent simultaneous malignancy resection of the colorectum or other organs (except gallbladder).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Postoperative unplanned reoperationwith in 90 days after surgery

The unplanned reoperation due to postoperative complications

Unplanned readmissionwith in 90 days after surgery

The unplanned readmission after discharge due to postoperative complications

Postoperative complicationswith in 90 days after surgery

The grades of postoperative complications were recorded following the Clavien-Dindo classification. Partial hepatic dysfunction or hepatic failure, biliary fistula, postoperative hemorrhage, pleural effusion, venous thrombosis, and surgical site infections were recorded.

Postoperative hospital staywith in 90 days after surgery

The days of hospital stay after operation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

First Affiliated Hospital, Medical College of Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

First Affiliated Hospital, Medical College of Zhejiang University
🇨🇳Hangzhou, Zhejiang, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.